Content area
Full text
SynapDx Corp., announced it has secured a $15.4 million funding round, led by Google Ventures. Foundation Medical Partners also joined the financing as a new investor alongside founding investors North Bridge Venture Partners and General Catalyst Partners.
In a release, the company noted that the funding will support the continued advancement of SynapDx as a next generation diagnostics and informatics company focused on pediatric neurodevelopmental disorders. SynapDx is currently developing a blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
SynapDx also announced the appointment of Google's Andrew Conrad, PhD, to the company's Board...